You are here

Amgen

Biopharma's biggest sellers – the oldies that just keep giving

Biopharma's biggest sellers – the oldies that just keep giving

Evaluate Pharma

Flag link:

Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi

Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi

Pharmaceutical Business Review

Flag link:

What Enbrel needs to do after its patent win

What Enbrel needs to do after its patent win

EP Vantage

Flag link:

Enbrel ruling lifts Amgen shares

Enbrel ruling lifts Amgen shares

BioCentury

Flag link:

3 Lung Cancer Stocks That Could Soar in September

3 Lung Cancer Stocks That Could Soar in September

Motley Fool

Flag link:

Amgen results beat estimates, lung cancer trial planned

Amgen results beat estimates, lung cancer trial planned

Yahoo/Reuters

clinical trials

Flag link:

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Fierce Pharma

Teva Pharmaceutical

Flag link:

AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout

AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout

Motley Fool

Flag link:

Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market

Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market

Fierce Pharma

Flag link:

These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger

These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger

Investors Business Daily

Bristol-Myers Squibb

Gilead Sciences

Flag link:

Emgality-maker Lilly courts payers with new migraine ER data

Emgality-maker Lilly courts payers with new migraine ER data

Fierce Pharma

cluster headache

Teva Pharmaceutical

Flag link:

Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs

Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs

Xconomy

Alzheimer's disease

BACE inhibitors

Flag link:

German court blocks sale of Sanofi, Regeneron cholesterol drug

German court blocks sale of Sanofi, Regeneron cholesterol drug

Biopharma Dive

Flag link:

Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug

Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug

Endpoints

Flag link:

3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal

3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal

Motley Fool

Array Biopharma

Gilead Sciences

Flag link:

Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

BioCentury

Flag link:

FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin

FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin

RAPS.org

Flag link:

Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?

Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?

Forbes

The Medicines Company

PCSK9 inhibitors

Flag link:

3 takeaways from cancer's biggest conference

3 takeaways from cancer's biggest conference

Biopharma Dive

accelerated approvals

Turning Point Therapeutics

Flag link:

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

Xconomy

Moderna Therapeutics

Nektar Therapeutics

Blueprint Medicines

Flag link:

Pages